Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / India

India's IBPL To Launch Oncology Biotech Products

February 2008 | Company News Alert

Demonstrating faith in the Gulf states' appetite for novel drugs, India's Intas Biopharmaceuticals (IBPL) is to register itself in the Gulf Co-operation Council (GCC) region. IBPL is initially planning to launch three products to treat certain cancers and their side effects in the GCC. The products due to be launched are Neukine (rHu G-CSF), Erykine (rHu EPO) and Intalfa (rHu interferon alpha

To read the full article, please choose one of the following options:

Subcribers please log in

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries